India to Saudi Arabia: Doxorubicin Export Trade Route

The India to Saudi Arabia Doxorubicin corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $2.2M USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 40% of all export value, reflecting the consolidated nature of India's doxorubicin manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $46.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with doxorubicin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 11.6%, placing it at rank #12 among India's top doxorubicin export destinations globally.

On the import side, key buyers of Indian doxorubicin in Saudi Arabia include SAB P.O BOX67 JEDDAH 21411, SUDAIR PHARMA UNIT 6 P.O.BOX 19047, SUDAIR PHARMA UNIT 6 and 20 others. SAB P.O BOX67 JEDDAH 21411 is the single largest importer with 3 shipments valued at $642.0K USD.

India's doxorubicin exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. DR.REDDY'S LABORATORIES LTD with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD — together account for 98% of total trade value on this route. The average shipment value of $46.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as doxorubicin hcl liposome inj. (20mg/10ml) and 300026772 doxorubicin hydrochloride lipo , suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SAB P.O BOX67 JEDDAH 21411 is the largest importer with 3 shipments worth $642.0K USD — representing 30% of all doxorubicin imports from India on this route. A total of 23 buyers are active on this corridor.